Nephroprotective action of tocotrienol-rich fraction (TRF) from palm oil against potassium dichromate (K2Cr2O7)-induced acute renal injury in rats

Chemico-Biological Interactions

Volumn 186, Issue 2, 2010, Pages 228-238

  Khan, Mohd Rashid ^a   Siddiqui, Shabeena ^a   Parveen, Kehkashan ^a   Javed, Saleem ^a   Diwakar, Sandhya ^b   Siddiqui, Waseem A ^a  

^a HAMDARD UNIVERSITY   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Acute renal injury; Glucosuria; Nephrotoxicity; Potassium dichromate; Proteinuria; Tocotrienols

Indexed keywords

ALPHA TOCOTRIENOL; CATALASE; DICHROMATE POTASSIUM; GLUTATHIONE; MALONALDEHYDE; NITRATE; NITRITE; PALM OIL; PROTEIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIPID PEROXIDATION; MALE; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; RAT; RENAL PROTECTION; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CATALASE; DISEASE MODELS, ANIMAL; GLOMERULAR FILTRATION RATE; GLUTATHIONE; KIDNEY CORTEX; KIDNEY FAILURE, ACUTE; KIDNEY TUBULES, PROXIMAL; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; PLANT OILS; POTASSIUM DICHROMATE; RATS; RATS, WISTAR; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; TOCOTRIENOLS;

ANIMALIA; RATTUS;

EID: 77953538687     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.04.025     Document Type: Article

References (53)

1. Cohen M.D., Kargacin B., Klein C.B., Costa M. Mechanisms of chromium carcinogenicity and toxicity. Crit. Rev. Toxicol. 1993, 23:255-281.
2. Bagchi D., Hassoun E.A., Bagchi M., Stohs S.J. Chromium-induced excretion of urinary lipid metabolites, DNA damage, nitric oxide production, and generation of reactive oxygen species in Sprague-Dawley rats. Comp. Biochem. Physiol. C: Pharmacol. Toxicol. Endocrinol. 1995, 110:177-187.
3. Appenroth D., Gambaryan S., Fries K.H., Braunlich H. Influence of metyrapon and phenobarbital on sodium dichromate nephrotoxicity in developing rats. J. Appl. Toxicol. 1990, 10:227-232.
4. Wang X., Qin Q., Xu X., Xu J., Wang J., Zhou J., Huang S., Zhai W., Zhou H., Chen J. Chromium-induced early changes in renal function among ferrochromium-producing workers. Toxicology 1994, 90:93-101.
5. Valko M., Morris H., Cronin M.T. Metals, toxicity and oxidative stress. Curr. Med. Chem. 2005, 12:1161-1208.
6. Stohs S.J., Bagchi D. Oxidative mechanisms in the toxicity of metal ions. Free Radic. Biol. Med. 1995, 18:321-336.
7. 7-induced nephrotoxicity. BMC Nephrol. 2005, 6:4.
8. Bagchi D., Vuchetich P.J., Bagchi M., Hassoun E.A., Tran M.X., Tang L., Stohs S.J. Induction of oxidative stress by chronic administration of sodium dichromate [chromium(VI)] and cadmium chloride [cadmium(II)] to rats. Free Radic. Biol. Med. 1997, 22:471-478.
9. Arreola-Mendoza L., Reyes J.L., Melendez E., Martin D., Namorado M.C., Sanchez E., Del Razo L.M. Alpha-tocopherol protects against the renal damage caused by potassium dichromate. Toxicology 2006, 218:237-246.
10. 7. Free Radic. Biol. Med. 2003, 34:1390-1398.
11. Fatima S., Mahmood R. Vitamin C attenuates potassium dichromate-induced nephrotoxicity and alterations in renal brush border membrane enzymes and phosphate transport in rats. Clin. Chim. Acta 2007, 386:94-99.
12. Yam-Canul P., Chirino Y.I., Sanchez-Gonzalez D.J., Martinez-Martinez C.M., Cruz C., Villanueva C., Pedraza-Chaverri J. Nordihydroguaiaretic acid attenuates potassium dichromate-induced oxidative stress and nephrotoxicity. Food Chem. Toxicol. 2008, 46:1089-1096.
13. Standeven A.M., Wetterhahn K.E. Possible role of glutathione in chromium(VI) metabolism and toxicity in rats. Pharmacol. Toxicol. 1991, 68:469-476.
14. 7)-induced oxidative damage and nephrotoxicity in rats. Chem. Biol. Interact. 2009, 181:343-350.
15. Kir H.M., Dillioglugil M.O., Tugay M., Eraldemir C., Ozdogan H.K. Effects of vitamins E, A and D on MDA, GSH, NO levels and SOD activities in 5/6 nephrectomized rats. Am. J. Nephrol. 2005, 25:441-446.
16. Kedziora-Kornatowska K., Szram S., Kornatowski T., Szadujkis-Szadurski L., Kedziora J., Bartosz G. Effect of vitamin E and vitamin C supplementation on antioxidative state and renal glomerular basement membrane thickness in diabetic kidney. Nephron Exp. Nephrol. 2003, 95:134-143.
17. Hahn S., Krieg R.J., Hisano S., Chan W., Kuemmerle N.B., Saborio P., Chan J.C. Vitamin E suppresses oxidative stress and glomerulosclerosis in rat remnant kidney. Pediatr. Nephrol. 1999, 13:195-198.
18. Appenroth D., Winnefeld K. Protective effect of vitamin E and C on cisplatin nephrotoxicity in developing rats. Arch. Toxicol. 1997, 71:677-683.
19. Sen C.K., Khanna S., Roy S. Tocotrienol: the natural vitamin E to defend the nervous system?. Ann. NY Acad. Sci. 2004, 1031:127-142.
20. Suarna C., Hood R.L., Dean R.T., Stocker R. Comparative antioxidant activity of tocotrienols and other natural lipid-soluble antioxidants in a homogeneous system, and in rat and human lipoproteins. Biochim. Biophys. Acta 1993, 1166:163-170.
21. Kamal-Eldin A., Appelqvist L.A. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids 1996, 31:671-701.
22. Packer L., Weber S.U., Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J. Nutr. 2001, 131:369S-373S.
23. Sen C.K., Khanna S., Roy S. Tocotrienols: vitamin E beyond tocopherols. Life Sci. 2006, 78:2088-2098.
24. Husain K., Francois R.A., Hutchinson S.Z., Neuger A.M., Lush R., Coppola D., Sebti S., Malafa M.P. Vitamin E delta-tocotrienol levels in tumor and pancreatic tissue of mice after oral administration. Pharmacology 2009, 83:157-163.
25. Qureshi A.A., Sami S.A., Salser W.A., Khan F.A. Dose-dependent suppression of serum cholesterol by tocotrienol-rich fraction (TRF25) of rice bran in hypercholesterolemic humans. Atherosclerosis 2002, 161:199-207.
26. Ng M.H., Choo Y.M., Ma A.N., Chuah C.H., Hashim M.A. Separation of vitamin E (tocopherol, tocotrienol, and tocomonoenol) in palm oil. Lipids 2004, 39:1031-1035.
27. Price R.G., Dance N., Richards B., Cattell W.R. The excretion of N-acetyl-β-glucosaminidase and β-galactosidase following surgery to the kidney. Clin. Chim. Acta 1970, 27:65-72.
28. Utley H.C., Bernheim F., Hochslein P. Effect of sulfhydryl reagent on peroxidation in micrisome. Arch. Biochem. Biophys. 1967, 260:521-531.
29. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 1979, 95:351-358.
30. Jollow D.J., Mitchell J.R., Zampaglione N., Gillette J.R. Bromobenzene induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974, 11:151-169.
31. Claiborne Catalase activity. CRC Handbook of Methods for Oxygen Radical Research 1985, 283-284. CRC Press, Boca Raton, FL. R.A. Green Wald (Ed.).
32. Miranda K.M., Espey M.G., Wink D.A., Rapid A. Simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 2001, 5:62-71.
33. Beda N., Nedospasov A. A spectrophotometric assay for nitrate in an excess of nitrite. Nitric Oxide 2005, 13:93-97.
34. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
35. Kirschbaum B.B., Sprinkel F.M., Oken D.E. Proximal tubule brush border alterations during the course of chromate nephropathy. Toxicol. Appl. Pharmacol. 1981, 58:19-30.
36. Wedeen R.P., Qian L.F. Chromium-induced kidney disease. Environ. Health Perspect. 1991, 92:71-74.
37. Aronson P.S., Sacktor B. Transport of d-glucose by brush border membranes isolated from the renal cortex. Biochim. Biophys. Acta 1974, 356:231-243.
38. Aronson P.S. Role of ion exchangers in mediating NaCl transport in the proximal tubule. Kidney Int. 1996, 49:1665-1670.
39. Heilig C.W., Brosius F.C., Henry D.N. Glucose transporters of the glomerulus and the implications for diabetic nephropathy. Kidney Int. Suppl. 1997, 60:S91-S99.
40. Jung J.S., Lee R.H., Koh S.H., Kim Y.K. Changes in expression of sodium cotransporters and aquaporin-2 during ischemia-reperfusion injury in rabbit kidney. Ren. Fail. 2000, 22:407-421.
41. Nissenson A.R. Acute renal failure: definition and pathogenesis. Kidney Int. Suppl. 1998, 66:S7-S10.
42. Appenroth D., Karge E., Kiessling G., Wechter W.J., Winnefeld K., Fleck C. LLU-alpha, an endogenous metabolite of gamma-tocopherol, is more effective against metal nephrotoxicity in rats than gamma-tocopherol. Toxicol. Lett. 2001, 122:255-265.
43. Hojo Y., Satomi Y. In vitro nephrotoxicity induced in mice by chromium(VI): involvement of glutathione and chromium(V). Biol. Trace Elem. Res. 1991, 31:21-31.
44. Salminen A., Vihko V. Lipid peroxidation in exercise myopathy. Exp. Mol. Pathol. 1983, 38:380-388.
45. Berlett B.S., Stadtman E.R. Protein oxidation in ageing, disease and oxidative stress. J. Biol. Chem. 1997, 272:20313-20316.
46. Imai T., Nishimaki K., Shiga T., Kawasaki S., Makuuchi M. Lipid peroxidation and antioxidant activities in regenerating liver after partial hepatectomy in splenectomized rats. Res. Exp. Med. 1996, 196:1-7.
47. Halliwell B.B., Gutteridge J.M.C. Free Radicals in Biology and Medicine 2002, vol. 3. Oxford University Press Inc., New York, pp. 105-245.
48. Kamat J.P., Devasagayam T.P.A. Tocotrienols from palm oil as potent inhibitors of lipid peroxidation and protein oxidation in rat brain mitochondria. Neurosci. Lett. 1995, 195:179-182.
49. Serbinova E., Kagan V., Han D., Packer L. Free radical recycling and intramembrane mobility in the antioxidant properties of alpha-tocopherol and alpha-tocotrienol. Free Radic. Biol. Med. 1991, 10:263-275.
50. Saito Y., Yoshida Y., Nishio K., Hayakawa M., Niki E. Characterization of cellular uptake and distribution of vitamin E. Ann. NY Acad. Sci. 2004, 1031:368-375.
51. Shichiri M., Takanezawa Y., Uchid K., Tamai H., Arai H. Protection of cerebellar granule cells by tocopherols and tocotrienols against methylmercury toxicity. Brain Res. 2007, 1182:106-115.
52. Moncada M., Palmer R.M., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991, 43:109-142.
53. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:4003-4008.